<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04347733</url>
  </required_header>
  <id_info>
    <org_study_id>2017-03-011-001</org_study_id>
    <nct_id>NCT04347733</nct_id>
  </id_info>
  <brief_title>Hyaluronidase in Intra-articular Steroid Injection Treating the Adhesive Capsulitis for Shoulder</brief_title>
  <official_title>Additive Effects of Hyaluronidase in Intra-articular Steroid Injection Treating the Initial Stage of Adhesive Capsulitis for Shoulder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Veterans Health Service Medical Center, Seoul, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Veterans Health Service Medical Center, Seoul, Korea</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adhesive capsulitis (AC) is painful and disabling condition that is associated with a gradual
      loss of shoulder motion. Intra-articular steroid injection is a common treatment in the
      initial painful stage of AC, and its use in combination with hyaluronidase may offer
      increased therapeutic efficacy owing to synergistic effects. We determined the therapeutic
      efficiency of the co-administration of hyaluronidase in early AC by evaluating symptomatic,
      anthropometric, and imaging changes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We enrolled eligible patients with primary adhesive capsulitis in the initial stage.The
      subjects were randomly assigned into 3 groups to receive ultrasound-guided intra-articular
      injections with 20 mg (group A) and 40 mg triamcinolone acetonide (group B) and 20 mg
      acetonide combined with hyaluronidase (group C). The outcome measures included the visual
      analogue scale (VAS), the shoulder disability questionnaire (SDQ), abduction and external
      rotation range of motion, and intra-sheath fluid (ISF) before treatment and at 2, 4, 8, and
      16 weeks after treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2, 2017</start_date>
  <completion_date type="Actual">July 16, 2019</completion_date>
  <primary_completion_date type="Actual">March 27, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of visual analogue scale (VAS)</measure>
    <time_frame>Evaluation at 5 time intervals: before injection and at 2, 4, 8, and 16 weeks after the injection</time_frame>
    <description>Evaluation for the change of VAS that means average degree of shoulder pain for 24 hours before the evaluation (from 0 to 10 points)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of shoulder disability questionnaire (SDQ)</measure>
    <time_frame>Evaluation at 5 time intervals: before injection and at 2, 4, 8, and 16 weeks after the injection</time_frame>
    <description>Evaluation for the change of SDQ that means the self-reported functional status in patients with shoulder disorders, comprised of 16 questions, reflecting the pain during various movements related with activities of daily living, with scores ranging from 0 (no disability) to 16 (greatest possible disability).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of degree for the abduction motion of shoulder</measure>
    <time_frame>Evaluation at 5 time intervals: before injection and at 2, 4, 8, and 16 weeks after the injection</time_frame>
    <description>Evaluation for the change of degree for the motion of shoulder, checked with an inclinometer, as a passive maneuver, in the supine position</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of degree for the flexion motion of shoulder</measure>
    <time_frame>Evaluation at 5 time intervals: before injection and at 2, 4, 8, and 16 weeks after the injection</time_frame>
    <description>Evaluation for the change of degree for the motion of shoulder, checked with an inclinometer, as a passive maneuver, in the supine position</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of area for the intra-sheath fluid</measure>
    <time_frame>Evaluation at 5 time intervals: before injection and at 2, 4, 8, and 16 weeks after the injection</time_frame>
    <description>Evaluation for the change of area for the intra-sheath fluid, checked and calculated ultrasonographically at the upper portion of the bicipital groove of the humerus.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Adhesive Capsulitis of Shoulder</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intra-articular injection, 20 mg (0.5 mL) of triamcinolone acetonide mixed with 2 mL of 2% lidocaine and 7.5 mL of normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>40 mg (1 mL) of triamcinolone acetonide mixed with 2 mL of 2% lidocaine and 7.0 mL of normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 mg (0.5 mL) of triamcinolone acetonide and 1 mL of hyaluronidase mixed with 2 mL of 2% lidocaine and 6.5 mL of normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triamcinolone Acetonide 40mg/mL</intervention_name>
    <description>We aimed to examine the therapeutic efficacy of the combination of hyaluronidase and steroid injection for adhesive capsulitis and to determine whether such a combination therapy might enable the total amount of steroids to be reduced.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyaluronidase Injection</intervention_name>
    <description>We aimed to examine the therapeutic efficacy of the combination of hyaluronidase and steroid injection for adhesive capsulitis and to determine whether such a combination therapy might enable the total amount of steroids to be reduced.</description>
    <arm_group_label>Group C</arm_group_label>
    <other_name>Hirax Inj® BMI KOREA Pharmaceutical, South Korea</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal findings on simple x-rays of the shoulder but limitations in passive range of
             motion on physical examination

          -  Increased intra-sheath fluid (ISF) sufficient to encircle the long head of the biceps
             tendon within the upper portion of the bicipital groove of the humerus.

        Exclusion Criteria:

          -  Ultrasonographic diagnosis of other concomitant fundamental abnormalities causing
             shoulder pain such as rotator cuff tear, bicipital tendon rupture, calcific
             tendinopathy, and subacromial-subdeltoid bursitis

          -  A history of shoulder injury

          -  A history of more than 1 year of conservative treatment for chronic shoulder pain

          -  Corticosteroid or hyaluronidase injections within the prior 6 months

          -  Hemiplegic shoulder

          -  Self-reported history consistent with scapula fracture or disarticulation

          -  Ipsilaterally cervical herniated intervertebral disc or brachial plexus injury

          -  Diabetes mellitus refractory to insulin therapy or glycated hemoglobin greater than
             6.5

          -  Refusal to participate in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wonjae Lee, MD, Ph D</last_name>
    <role>Study Director</role>
    <affiliation>Veterans Health Service Medical Center, Seoul, Korea</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Veterans Health Service Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05368</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Fields BKK, Skalski MR, Patel DB, White EA, Tomasian A, Gross JS, Matcuk GR Jr. Adhesive capsulitis: review of imaging findings, pathophysiology, clinical presentation, and treatment options. Skeletal Radiol. 2019 Aug;48(8):1171-1184. doi: 10.1007/s00256-018-3139-6. Epub 2019 Jan 3. Review.</citation>
    <PMID>30607455</PMID>
  </reference>
  <reference>
    <citation>Ahn JH, Lee DH, Kang H, Lee MY, Kang DR, Yoon SH. Early Intra-articular Corticosteroid Injection Improves Pain and Function in Adhesive Capsulitis of the Shoulder: 1-Year Retrospective Longitudinal Study. PM R. 2018 Jan;10(1):19-27. doi: 10.1016/j.pmrj.2017.06.004. Epub 2017 Jun 12.</citation>
    <PMID>28619380</PMID>
  </reference>
  <reference>
    <citation>Tandon A, Dewan S, Bhatt S, Jain AK, Kumari R. Sonography in diagnosis of adhesive capsulitis of the shoulder: a case-control study. J Ultrasound. 2017 Aug 21;20(3):227-236. doi: 10.1007/s40477-017-0262-5. eCollection 2017 Sep.</citation>
    <PMID>28900523</PMID>
  </reference>
  <reference>
    <citation>Byun SD, Park DH, Hong YH, Lee ZI. The additive effects of hyaluronidase in subacromial bursa injections administered to patients with peri-articular shoulder disorder. Ann Rehabil Med. 2012 Feb;36(1):105-11. doi: 10.5535/arm.2012.36.1.105. Epub 2012 Feb 29.</citation>
    <PMID>22506242</PMID>
  </reference>
  <results_reference>
    <citation>Buhren BA, Schrumpf H, Hoff NP, Bölke E, Hilton S, Gerber PA. Hyaluronidase: from clinical applications to molecular and cellular mechanisms. Eur J Med Res. 2016 Feb 13;21:5. doi: 10.1186/s40001-016-0201-5. Review.</citation>
    <PMID>26873038</PMID>
  </results_reference>
  <results_reference>
    <citation>Cho CH, Song KS, Kim BS, Kim DH, Lho YM. Biological Aspect of Pathophysiology for Frozen Shoulder. Biomed Res Int. 2018 May 24;2018:7274517. doi: 10.1155/2018/7274517. eCollection 2018. Review.</citation>
    <PMID>29992159</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 9, 2020</study_first_submitted>
  <study_first_submitted_qc>April 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Veterans Health Service Medical Center, Seoul, Korea</investigator_affiliation>
    <investigator_full_name>Wonjae Lee, MD PhD</investigator_full_name>
    <investigator_title>Director for the department of physical medicine and rehabilitation</investigator_title>
  </responsible_party>
  <keyword>Intra-articular injections</keyword>
  <keyword>Steroids</keyword>
  <keyword>Hyaluronidase</keyword>
  <keyword>Ultrasonography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bursitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

